Elicio Therapeutics, Inc.
ELTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001601485
No open-market purchases or sales by Elicio Therapeutics, Inc. insiders were filed in the last 90 days; 48 institutions reported holding it in 13F filings for Q2 2026, worth $15.3M in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in Elicio Therapeutics, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 28
- −2 vs. Q4 2022
- Shares held
- 4.47M
- −438.6K (−8.9%) vs. Q4 2022
- Total value
- $2.56M
- −$1.42M (−35.6%) vs. Q4 2022
- New holders
- 0
- 7 more added
- Sold out
- 2
- 7 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ELTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 48 | $15.3M |
| Q1 2026 | 47 | $28.2M |
| Q4 2025 | 37 | $16.6M |
| Q3 2025 | 28 | $20.9M |
| Q2 2025 | 21 | $11.2M |
| Q1 2025 | 24 | $9.80M |
| Q4 2024 | 17 | $2.25M |
| Q3 2024 | 18 | $2.48M |
| Q2 2024 | 20 | $2.68M |
| Q1 2024 | 18 | $3.08M |
| Q4 2023 | 18 | $2.78M |
| Q3 2023 | 18 | $2.80M |
| Q2 2023 | 15 | $2.71M |
| Q1 2023 | 28 | $2.56M |
| Q4 2022 | 30 | $3.98M |
| Q3 2022 | 38 | $4.71M |
| Q2 2022 | 43 | $5.90M |
| Q1 2022 | 47 | $13.8M |
| Q4 2021 | 53 | $20.3M |
| Q3 2021 | 47 | $69.3M |
| Q2 2021 | 41 | $66.5M |
| Q1 2021 | 41 | $92.0M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Elicio Therapeutics, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wells Fargo & Company | 148 | $86 | 0.00% | +2+1.4% | Added |
| Barclays PLC | 3,617 | $2.10K | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 3,743 | $2.17K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 4,120 | $2.39K | 0.00% | −666−13.9% | Reduced |
| Tower Research Capital LLC (TRC) | 6,205 | $4.00K | 0.00% | +2,626+73.4% | Added |
| State Street Corp | 12,700 | $7.37K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 14,492 | $8.41K | 0.00% | +4,573+46.1% | Added |
| BLB&B Advisors, LLC | 15,495 | $8.99K | 0.00% | 00.0% | Unchanged |
| Steward Partners Investment Advisory, LLC | 15,558 | $9.02K | 0.00% | 00.0% | Unchanged |
| CAPROCK Group, Inc. | 15,726 | $9.12K | 0.00% | 00.0% | Unchanged |
| Prudential Financial Inc | 16,600 | $9.63K | 0.00% | −17,800−51.7% | Reduced |
| Acadian Asset Management LLC | 23,804 | $13.0K | 0.00% | −900−3.6% | Reduced |
| Patriot Financial Group Insurance Agency, LLC | 24,500 | $14.2K | 0.00% | +3,000+14.0% | Added |
| Bank of America Corp | 31,135 | $18.1K | 0.00% | +10,745+52.7% | Added |
| Northern Trust Corp | 33,788 | $19.6K | 0.00% | 00.0% | Unchanged |
| Valeo Financial Advisors, LLC | 36,951 | $21.4K | 0.00% | 00.0% | Unchanged |
| Cannell Capital LLC | 40,181 | $23.3K | 0.00% | 00.0% | Unchanged |
| Birchview Capital, LP | 54,392 | $32.0K | 0.03% | 00.0% | Unchanged |
| BlackRock Inc. | 57,054 | $33.1K | 0.00% | +1,782+3.2% | Added |
| Raymond James & Associates | 60,000 | $34.8K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 69,365 | $40.0K | 0.00% | −5,977−7.9% | Reduced |
| Renaissance Technologies LLC | 93,015 | $54.0K | 0.00% | −28,685−23.6% | Reduced |
| Geode Capital Management, LLC | 167,403 | $97.1K | 0.00% | −1,033−0.6% | Reduced |
| Bridgeway Capital Management, LLC | 175,000 | $101.5K | 0.00% | 00.0% | Unchanged |
| Vanguard Group Inc | 644,035 | $373.5K | 0.00% | 00.0% | Unchanged |
| CM Management, LLC | 800,000 | $464.0K | 0.55% | +67,822+9.3% | Added |
| Nantahala Capital Management, LLC | 982,743 | $540.5K | 0.05% | −50,402−4.9% | Reduced |
| BVF Inc | 1,071,297 | $621.4K | 0.02% | 00.0% | Unchanged |
| Park West Asset Management LLC | 0 | $0 | 0.00% | −370,724−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −52,913−100.0% | Sold out |